This chapter explores the use of psychedelics to assist patients with terminal cancer in accepting their diagnosis, while acknowledging the need for alternative approaches. The potential effects of sleep on attention and time perception are also discussed, alongside excitement for ongoing clinical trials while expressing concerns about premature results.
Andrew Huberman is a neuroscientist and tenured professor in the Department of Neurobiology at the Stanford University School of Medicine. He has made numerous important contributions to the fields of brain development, brain plasticity, and neural regeneration and repair.